115 related articles for article (PubMed ID: 27060774)
1. Coadminstration of L. major amastigote class I nuclease (rLmaCIN) with LPD nanoparticles delays the progression of skin lesion and the L. major dissemination to the spleen in BALB/c mice-based experimental setting.
Fakhraee F; Badiee A; Alavizadeh SH; Jalali SA; Chavoshian O; Khamesipour A; Mahboudi F; Jaafari MR
Acta Trop; 2016 Jul; 159():211-8. PubMed ID: 27060774
[TBL] [Abstract][Full Text] [Related]
2. The role of LPD-nanoparticles containing recombinant major surface glycoprotein of Leishmania (rgp63) in protection against leishmaniasis in murine model.
Firouzmand H; Sahranavard M; Badiee A; Khamesipour A; Alavizadeh SH; Samiei A; Soroush D; Tavassoti Kheiri M; Mahboudi F; Jaafari MR
Immunopharmacol Immunotoxicol; 2018 Feb; 40(1):72-82. PubMed ID: 29210292
[TBL] [Abstract][Full Text] [Related]
3. The role of liposome-protamine-DNA nanoparticles containing CpG oligodeoxynucleotides in the course of infection induced by Leishmania major in BALB/c mice.
Alavizadeh SH; Badiee A; Khamesipour A; Jalali SA; Firouzmand H; Abbasi A; Jaafari MR
Exp Parasitol; 2012 Nov; 132(3):313-9. PubMed ID: 22819791
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Leishmanization Using
Keshavarzian N; Noroozbeygi M; Haji Molla Hoseini M; Yeganeh F
Front Immunol; 2020; 11():1725. PubMed ID: 33193290
[No Abstract] [Full Text] [Related]
5. Mononuclear cells from patients recovered from cutaneous leishmaniasis respond to Leishmania major amastigote class I nuclease with a predominant Th1-like response.
Farajnia S; Mahboudi F; Ajdari S; Reiner NE; Kariminia A; Alimohammadian MH
Clin Exp Immunol; 2005 Mar; 139(3):498-505. PubMed ID: 15730396
[TBL] [Abstract][Full Text] [Related]
6. DNA-protein immunization using Leishmania peroxidoxin-1 induces a strong CD4+ T cell response and partially protects mice from cutaneous leishmaniasis: role of fusion murine granulocyte-macrophage colony-stimulating factor DNA adjuvant.
Bayih AG; Daifalla NS; Gedamu L
PLoS Negl Trop Dis; 2014 Dec; 8(12):e3391. PubMed ID: 25500571
[TBL] [Abstract][Full Text] [Related]
7. Immunization against full-length protein and peptides from the Lutzomyia longipalpis sand fly salivary component maxadilan protects against Leishmania major infection in a murine model.
Wheat WH; Arthun EN; Spencer JS; Regan DP; Titus RG; Dow SW
Vaccine; 2017 Dec; 35(48 Pt B):6611-6619. PubMed ID: 29079105
[TBL] [Abstract][Full Text] [Related]
8. Leishmania tropica: suggestive evidences for the effect of infectious dose on pathogenicity and immunogenicity in an experimental model.
Rostamian M; Jafari D; Abolghazi M; Farahani H; Niknam HM
Parasitol Res; 2018 Sep; 117(9):2949-2956. PubMed ID: 29978420
[TBL] [Abstract][Full Text] [Related]
9. The role of liposome size on the type of immune response induced in BALB/c mice against leishmaniasis: rgp63 as a model antigen.
Badiee A; Khamesipour A; Samiei A; Soroush D; Shargh VH; Kheiri MT; Barkhordari F; Robert Mc Master W; Mahboudi F; Jaafari MR
Exp Parasitol; 2012 Dec; 132(4):403-9. PubMed ID: 22982807
[TBL] [Abstract][Full Text] [Related]
10. Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8(+) T lymphocyte activation.
Rafati S; Kariminia A; Seyde-Eslami S; Narimani M; Taheri T; Lebbatard M
Vaccine; 2002 Jun; 20(19-20):2439-47. PubMed ID: 12057598
[TBL] [Abstract][Full Text] [Related]
11. β-Adrenergic blockade protects BALB/c mice against infection with a small inoculum of Leishmania mexicana mexicana (LV4).
García-Miss Mdel R; Mut-Martín MC; Góngora-Alfaro JL
Int Immunopharmacol; 2015 Jan; 24(1):59-67. PubMed ID: 25461918
[TBL] [Abstract][Full Text] [Related]
12. Immunoliposomes containing Soluble Leishmania Antigens (SLA) as a novel antigen delivery system in murine model of leishmaniasis.
Eskandari F; Talesh GA; Parooie M; Jaafari MR; Khamesipour A; Saberi Z; Abbasi A; Badiee A
Exp Parasitol; 2014 Nov; 146():78-86. PubMed ID: 25246326
[TBL] [Abstract][Full Text] [Related]
13. Alginate microspheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN induced partial protection and enhanced immune response against murine model of leishmaniasis.
Tafaghodi M; Eskandari M; Khamesipour A; Jaafari MR
Exp Parasitol; 2011 Oct; 129(2):107-14. PubMed ID: 21767536
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.
Iborra S; Carrión J; Anderson C; Alonso C; Sacks D; Soto M
Infect Immun; 2005 Sep; 73(9):5842-52. PubMed ID: 16113303
[TBL] [Abstract][Full Text] [Related]
15. Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone.
Li J; Nolan TJ; Farrell JP
Exp Parasitol; 1997 Sep; 87(1):47-57. PubMed ID: 9287957
[TBL] [Abstract][Full Text] [Related]
16. Biochemical analysis and immunogenicity of Leishmania major amastigote fractions in cutaneous leishmaniasis.
Rafati S; Couty-Jouve S; Alimohammadian MH; Louis JA
Clin Exp Immunol; 1997 Nov; 110(2):203-11. PubMed ID: 9367403
[TBL] [Abstract][Full Text] [Related]
17. Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis.
Zadeh-Vakili A; Taheri T; Taslimi Y; Doustdari F; Salmanian AH; Rafati S
Vaccine; 2004 May; 22(15-16):1930-40. PubMed ID: 15121305
[TBL] [Abstract][Full Text] [Related]
18. Codelivery of DNA vaccination encoding LeIF gene and IL-12 increases protection against Leishmania major infection in BALB/c mice.
Maspi N; Ghaffarifar F; Sharifi Z; Dalimi A
Parasite Immunol; 2016 Apr; 38(4):228-35. PubMed ID: 26868280
[TBL] [Abstract][Full Text] [Related]
19. Immunity to Lutzomyia whitmani Saliva Protects against Experimental Leishmania braziliensis Infection.
Gomes R; Cavalcanti K; Teixeira C; Carvalho AM; Mattos PS; Cristal JR; Muniz AC; Miranda JC; de Oliveira CI; Barral A
PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005078. PubMed ID: 27812113
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis.
Ramírez L; Santos DM; Souza AP; Coelho EA; Barral A; Alonso C; Escutia MR; Bonay P; de Oliveira CI; Soto M
Vaccine; 2013 Feb; 31(9):1312-9. PubMed ID: 23313653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
